↓ Skip to main content

PCSK9 Inhibition: New Treatment Options and Perspectives to Lower Atherogenic Lipoprotein Particles and Cardiovascular Risk

Overview of attention for article published in Current Atherosclerosis Reports, July 2019
Altmetric Badge

Mentioned by

twitter
1 tweeter
Title
PCSK9 Inhibition: New Treatment Options and Perspectives to Lower Atherogenic Lipoprotein Particles and Cardiovascular Risk
Published in
Current Atherosclerosis Reports, July 2019
DOI 10.1007/s11883-019-0802-x
Pubmed ID
Authors

Julia Brandts, Dirk Müller-Wieland

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 July 2019.
All research outputs
#11,906,781
of 13,429,401 outputs
Outputs from Current Atherosclerosis Reports
#492
of 532 outputs
Outputs of similar age
#152,987
of 187,936 outputs
Outputs of similar age from Current Atherosclerosis Reports
#7
of 10 outputs
Altmetric has tracked 13,429,401 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 532 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.0. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 187,936 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 10 others from the same source and published within six weeks on either side of this one. This one has scored higher than 3 of them.